Whitebox Advisors’s SBC Medical Group Warrants SBCWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.05K Hold
35,000
﹤0.01% 634
2026
Q1
$9.63K Hold
35,000
﹤0.01% 537
2025
Q4
$7.11K Hold
35,000
﹤0.01% 467
2025
Q3
$7.3K Hold
35,000
﹤0.01% 400
2025
Q2
$6.76K Hold
35,000
﹤0.01% 351
2025
Q1
$6.51K Hold
35,000
﹤0.01% 276
2024
Q4
$8.4K Hold
35,000
﹤0.01% 226
2024
Q3
$5.25K Hold
35,000
﹤0.01% 228
2024
Q2
$2.48K Hold
35,000
﹤0.01% 282
2024
Q1
$1.23K Hold
35,000
﹤0.01% 316
2023
Q4
$987 Hold
35,000
﹤0.01% 294
2023
Q3
$2.1K Hold
35,000
﹤0.01% 317
2023
Q2
$2.08K Hold
35,000
﹤0.01% 361
2023
Q1
$1.66K Hold
35,000
﹤0.01% 517
2022
Q4
$1.93K Buy
+35,000
New +$1.62K ﹤0.01% 644

Other funds holding SBCWW

Whitebox Advisors's SBCWW Position: Q2 2026 in Review

Whitebox Advisors held its SBC Medical Group Warrants (SBCWW) position steady in Q2 2026 at 35,000 shares worth $8.05K. The position accounts for ﹤0.01% of the portfolio, ranked #634.

Whitebox Advisors first reported a position in SBCWW in Q4 2022 and has held it in 15 quarters since. The position peaked at $9.63K in Q1 2026. 17 funds tracked by Wall St. Rank hold SBCWW as of Q2 2026.

  • Whitebox Advisors held 35,000 shares of SBC Medical Group Warrants worth $8.05K as of Q2 2026.
  • Whitebox Advisors left its SBC Medical Group Warrants share count unchanged in Q2 2026.
  • SBC Medical Group Warrants made up ﹤0.01% of Whitebox Advisors's portfolio in Q2 2026, its #634 holding.
  • Whitebox Advisors first reported a position in SBC Medical Group Warrants in Q4 2022 and has held it in 15 quarters since.
  • Whitebox Advisors's SBC Medical Group Warrants position peaked at $9.63K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q2 2026.

Based on Whitebox Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.